Skip to main content

Irini Kantopoulos

Biotech Analyst and Portfolio Manager at Fidelity Investments, managing the Fidelity Advisor Biotechnology Fund

Aug 11, 2026

8:07
what has been happening with biotech stocks? What is driving this most recent surge right now?
8:11
Well, so in 2021, biotech was really the savior, right? It allowed all of us to get our COVID vaccines and rejoin humanity.
8:19
And so generalists were like, what is this biotech? Everything seems to work.
8:22
If we can go from nothing to a COVID vaccine in under 12 months, that's amazing.
8:27
Tell me more about these biotech names.
8:29
Everything worked in 2021.
8:31
The number of biotech names quintupled.
13:31
But I'm wondering from you, are we just in the infancy stages of this or have we not even started yet? You know, where are we in the timeline of AI impacting drug development and, you know, cures for all different kinds of diseases?

We value your privacy

We use cookies to understand how you use our platform and to improve your experience. Click “Accept All” to consent, or “Decline non-essential” to opt out of non-essential cookies. Read our Privacy Policy.